Abstract
The Electrocardiogram (ECG) serves as an integral tool in the diagnosis and management of a variety of cardiac diseases. It visualises electrical activity in the heart, offering insights into several cardiac processes, including ventricular repolarisation. The morphology of the T-wave observed on ECGs during this repolarisation phase varies and can be peaked, flat, inverted, or biphasic, each representing different cardiac conditions. Despite their prevalence, the interpretation of these patterns remains challenging. Therefore, we proposed the Simplified Egg and Changing Yolk Model, a novel idea to aid in the understanding of these T-wave morphologies in ECGs.
The proposed Simplified Egg and Changing Yolk Model was developed through an analysis of various T-wave morphologies and their corresponding clinical implications. The model was further designed to conceptualise the ST interval and the T-wave as a single unit, contributing to a simplified yet comprehensive understanding of ventricular repolarisation. In this context, the ‘Q-wave start to T-wave peak interval’(QTp) was compared to the more commonly used ‘corrected QT-interval’ (QTc) for assessing the risk of arrhythmia and the effects of medication that prolong the QT-interval.
The Simplified Egg and Changing Yolk Model could effectively explain and interpret the variation of ECG patterns associated with ventricular repolarisation. It provided insight into the relevance of deflections seen during this phase. Importantly, the model identified QTp as a more reliable measure than QTc for assessing arrhythmia risk and evaluating medication impacts on the QT-interval.
Our model offers a significant enhancement to the understanding of ventricular repolarisation and its manifestation on ECGs. By emphasising the superiority of QTp over QTc in clinical assessment, this model can have significant impact in clinical practice.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by Aberystwyth University "Technology Transfer Grant Development Award" and AberCollab.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study used ECG traces from PhysioNet. Reference: Perez Alday EA, Gu A, Shah A, et al.: Classification of 12-lead ECGs: The PhysioNet/Computing in Cardiology Challenge 2020 [Internet]. PhysioNet, [cited 2024 Dec 11],. Available from: https://physionet.org/content/challenge-2020/1.0.2/
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
The study used ECG traces from PhysioNet. Reference: Perez Alday EA, Gu A, Shah A, et al.: Classification of 12-lead ECGs: The PhysioNet/Computing in Cardiology Challenge 2020 [Internet]. PhysioNet, [cited 2024 Dec 11],. Available from: https://physionet.org/content/challenge-2020/1.0.2/
